Editor-in-Chief
CRISPR gene editing offers a potential alternative.
A new study by Intellia Therapeutics aims to treat hereditary angioedema using CRISPR technology. Bradykinin is responsible for vascular permeability, where significant increases in bradykinin caused by stress, illness, or trauma leads to severe, painful, and life-threatening swelling. The molecular mechanisms that drive the angioedema seen in the limbs, abdomen, and throat of individuals affected by the disease are caused by mutations that produce a dysfunctional protein called C1-esterase inhibitor, which controls the levels of bradykinin in the blood.
Therapeutic strategies that treat hereditary angioedema work by blocking kallikrein, a protein that upregulates the production of bradykinin. Since hereditary angioedema is a lifelong chronic disease, people suffering from continual swelling will have to take kallikrein inhibitors for life.
CRISPR gene editing offers a potential alternative. The Intellia study enrolled 3 individuals, all received a low dose of the CRISPR lipid nanoparticle and all three saw a 65% decrease in kallikrein at 8 and 10 weeks. An additional 3 patients were administered a higher dose of the CRISPR lipid nanoparticle, and a 92% decrease in kallikrein was observed.
All patients prior to treatment were experiencing severe swelling 3-7 times a month. After CRISPR therapy, no swelling was experienced, and all patients were able to stop the drugs they were taking to prevent swelling. The ability to intravenously inject CRISPR technology instead of ex vivo gene editing allows for a broad range of therapeutic applications where cures for hereditary genetic diseases were once fairy tales you told your children at bedtime.
See More Design Blog Posts from Axxiem:
CRISPR Engineered Bioimplants Inflammation is a natural and necessary biological process that helps with wound healing as well as combating infection. However, the adage “too much of a good thing” is as relevant in a biological system as in our Read more
New philanthropic venture provides free open access software to help university scientist remain on the cutting edge of research A new 40-million-dollar philanthropic initiative named “Virtual institute for Scientific Software” was created by Eric Schmidt (former Google CEO) and Wendy Read more
The CORD7 Mutation Found in Humans Increases Verbal IQ and Working Memory Intelligence in its rawest form is not equally distributed among the human population. While many can critically think and problem solve, others lack these skillsets. However, what is Read more